Ilona Reischl

Ilona Reischl joined the Austrian Medicines and Medical Devices Agency AGES MEA in March 2006 and has been affiliated with the Clinical Trials Unit since then as a quality assessor and as head of unit until 2019. She has represented Austria in the BWP and CAT and in associated regulatory activities. Since 2019 she has focused on scientific and regulatory issues on the European level. In 2023 she was elected chair of the EMA Committee for Advanced Therapies. A keen interest in innovation has led to active involvement in manufacturing, procedural and scientific issues pertaining to biotech products in general and ATMPs in particular. Current additional regulatory activities focus on the interface of medicinal products and medical devices, including in vitro diagnostics during the life-cycle of medicines.